A

Ashishkumar

Active Director Designated Partner DIN 09149489
DIN 09149489 First appointment Apr 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashishkumar

Data last updated:

Ashishkumar is a Designated Partner at Remedi Speciality Medicines Llp (since 2021). The company operates in Pharma.

DIN 09149489
Primary Designation Designated Partner
Industry Pharma
First Appointment 01 Apr 2021
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner01 Apr 20212016Active

Board colleagues of Ashishkumar

NameDINCompanyDesignation
Anil Kumar Jain Shanta07132216Remedi Speciality Medicines LlpDesignated Partner
Babithajain07869487Remedi Speciality Medicines LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Remedi Speciality Medicines Llp
Premium access

Shareholding and investment profile for Ashishkumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashishkumar

Ashishkumar currently holds 1 directorship: Remedi Speciality Medicines Llp (Designated Partner, since 01 Apr 2021).

Ashishkumar was first appointed on 01 Apr 2021 as Designated Partner at Remedi Speciality Medicines Llp.

The current boards of Ashishkumar's companies include Anil Kumar Jain Shanta (Remedi Speciality Medicines Llp), Babithajain (Remedi Speciality Medicines Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available